Veeva Systems (VEEV) kicked off Q1 2027 with revenue of US$882.9 million and basic EPS of US$1.60, against a backdrop of trailing 12 month EPS of US$5.75 and total revenue of about US$3.3 billion that has been reported growing around 11.2% year over year. Over recent quarters, revenue has moved from US$759.0 million in Q1 2026 through US$835.9 million in Q4 2026 to US$882.9 million in Q1 2027, while basic EPS has shifted from US$1.40 to US$1.49 and then to US$1.60 over the same period, setting up this release as another checkpoint on how net profit margins are holding up for long term holders.

See our full analysis for Veeva Systems.

With the headline numbers on the table, the next step is to see how this earnings run rate lines up with the widely followed narratives around Veeva’s growth, profitability and risk profile.

28.4% Net Margin Underpins Q1 Profitability

• Over the last 12 months, Veeva generated US$941.7 million in net income on US$3.3b of revenue, which works out to a 28.4% net profit margin compared with 27.3% a year earlier.
• What stands out for the bullish view is that this margin profile lines up with the idea of AI and platform products supporting earnings quality, yet there is still some gap to bullish assumptions that margins could move toward 35% over time.
  • Bullish analysts talk about higher value software and AI agents supporting margin expansion, and the move from 27.3% to 28.4% over the last year is consistent with that direction.
  • At the same time, the current 28.4% margin is below the 35% margin level used in the more optimistic scenario, so anyone leaning on that case needs to be comfortable that there is still a fair amount of improvement required from here.

20.6% Earnings Growth Meets Bear Concerns

• Trailing 12 month earnings rose 20.6% year over year to US$941.7 million, while analysts are expecting future earnings growth of about 12.6% per year, which is below the 16.2% forecast for the broader US market.
• Bears focus on the idea that future growth could be more moderate than the past, and the step down from 20.6% recent earnings growth to a 12.6% forecast growth rate is exactly the kind of slowdown they point to.
  • Bearish narratives assume revenue growth closer to 11.9% a year with margins holding around current levels, which is not far from the 11.2% trailing revenue growth and 28.4% margin in the recent data.
  • This alignment between recent growth, the 12.6% earnings growth forecast and the lower growth assumptions in the cautious view makes it easier for skeptics to argue that the faster multi year growth phase may already be behind the company.

Bears arguing that growth is already slowing might be missing how new products and AI tools could extend the earnings story if adoption holds up, so it can be useful to see how the more optimistic investors frame that path through the 🐂 Veeva Systems Bull Case

P/E Of 31x And DCF Fair Value Tension

• Veeva trades on a trailing P/E of 31x at a share price of US$178.60, compared with a peer average P/E of 33.5x, a Global Healthcare Services average of 26.6x, and a DCF fair value of about US$284.86 per share.
• Critics highlight that the stock is priced above the broader industry on P/E while growth forecasts are below the US market, yet the DCF fair value and analyst target of US$249.71 create an interesting tension between multiples and valuation models.
  • The 31x P/E is lower than the 33.5x peer average, which supports the idea that the stock is not the most expensive in its closer peer group despite the premium to the wider industry.
  • At the same time, the gap between the US$178.60 share price, the US$284.86 DCF fair value and the US$249.71 target suggests that valuation models are embedding higher earnings and margin outcomes than currently visible in trailing numbers.

For anyone weighing those valuation gaps against the risk that growth forecasts moderate further, it helps to see how the more cautious investors frame the downside case through the 🐻 Veeva Systems Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Veeva Systems on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With sentiment split between growth optimism and caution on valuation, this is a good moment to move quickly and review the numbers yourself. To see what optimistic investors are focusing on, take a closer look at the company's 3 key rewards

See What Else Is Out There

Veeva’s slower 12.6% earnings growth outlook versus recent 20.6% earnings growth, paired with a 31x P/E and valuation tension, leaves some investors hesitant.

If that mix of moderating growth expectations and a full looking P/E makes you cautious, broaden your watchlist with 47 high quality undervalued stocks while sentiment is still divided.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.